Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fürst

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|June 5, 1992
Activator proteins and topology of lysosomal sphingolipid catabolismW Fürst, K Sandhoff
Journal of Chromatography|July 1, 1992
Simultaneous determination of myocardial nucleotides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatographyW Fürst, S Hallström
Die Pharmazie|June 1, 1991
[Phenytoin and phenytoin derivatives for local administration]W Fürst, R Wildner
Die Pharmazie|January 1, 1989
[Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 8. Biotransformation of the active agents]M Becher, W Fürst
Die Pharmazie|August 1, 1985
[The pharmaceutical and biopharmaceutical assessment of acetylaminonitropropoxybenzene (Falimint). 6. Quantitative composition of metabolites]K Gerlach, J Metzner, W Fürst
Biological Chemistry Hoppe-Seyler|May 1, 1988
The precursor of sulfatide activator protein is processed to three different proteinsW Fürst, W Machleidt, K Sandhoff
Die Pharmazie|August 1, 1983
[Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 3: Polarographic analysis and determination of active agents]K Gerlach, R Voigtländer, W Fürst
Die Pharmazie|February 1, 1980
[Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)]W Fürst, R Neubert, L Reppel
Die Pharmazie|February 1, 1987
[Drug permeation through artificial lipoid membranes. 20. The effectiveness of multiple-lamellar liposomes for evaluating drug transport]R Neubert, W Fürst, B Wurschi
Die Pharmazie|January 1, 1984
[Pharmaceutic and biopharmaceutic evaluation of acetylaminonitropropoxybenzene (Falimint). A Biotransformation of the active agent]K Gerlach, A Büge, G Peinhardt, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|June 5, 1992
Activator proteins and topology of lysosomal sphingolipid catabolismW Fürst, K Sandhoff
Journal of Chromatography|July 1, 1992
Simultaneous determination of myocardial nucleotides, nucleosides, purine bases and creatine phosphate by ion-pair high-performance liquid chromatographyW Fürst, S Hallström
Die Pharmazie|June 1, 1991
[Phenytoin and phenytoin derivatives for local administration]W Fürst, R Wildner
Die Pharmazie|January 1, 1989
[Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 8. Biotransformation of the active agents]M Becher, W Fürst
Die Pharmazie|August 1, 1985
[The pharmaceutical and biopharmaceutical assessment of acetylaminonitropropoxybenzene (Falimint). 6. Quantitative composition of metabolites]K Gerlach, J Metzner, W Fürst
Biological Chemistry Hoppe-Seyler|May 1, 1988
The precursor of sulfatide activator protein is processed to three different proteinsW Fürst, W Machleidt, K Sandhoff
Die Pharmazie|August 1, 1983
[Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropropoxybenzolum (Falimint). 3: Polarographic analysis and determination of active agents]K Gerlach, R Voigtländer, W Fürst
Die Pharmazie|February 1, 1980
[Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)]W Fürst, R Neubert, L Reppel
Die Pharmazie|February 1, 1987
[Drug permeation through artificial lipoid membranes. 20. The effectiveness of multiple-lamellar liposomes for evaluating drug transport]R Neubert, W Fürst, B Wurschi
Die Pharmazie|January 1, 1984
[Pharmaceutic and biopharmaceutic evaluation of acetylaminonitropropoxybenzene (Falimint). A Biotransformation of the active agent]K Gerlach, A Büge, G Peinhardt, et al.
Pageof 6